13F

Stock

Halozyme Therapeutics, Inc.

HALO · held by 17 managers

Reported value

$68.6M

Holders

17

+1 new · −0 exited

Holders’ est. mark

$7.71M

Price effect on 10 books still in the name

Largest holder

$28.6M

Alberta Investment Management Corp

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Alberta Investment Management Corp25M$28.6MHeld
BARCLAYS PLC564.5K$15.7M$9.46MCut−$2M
Cresset Asset Management, LLC289.7K$15.1MHeld
DANSKE BANK A/S89.3K$4.64M−$1.01MCut−$808.8K
Sanctuary Advisors, LLC27.1K$1.41M−$319.5KCut−$656.3K
National Philanthropic Trust18.5K$962.4KNew
Henshaw Capital LLC14.5K$753.7K−$170.8KCut−$345.6K
OP Asset Management Ltd8.82K$459.1K−$104KCut−$104K
NWAM LLC5.42K$325.3KHeld
ELEVATION POINT WEALTH PARTNERS, LLC4.66K$242.4K−$55KCut−$583K
INDEPENDENT FINANCIAL GROUP, LLC4.16K$216.4K−$48.9KCut−$48.3K
VIRTUS ADVISERS, LLC67.7K$213.9K−$40.8KCut−$40.8K
Leonteq Securities AG750$39K−$7.04KAdded$759
Prestige Wealth Management Group LLC14$729−$165Cut−$165
Essential Partners LLC3$156Held

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.